-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Lyell Immunopharma, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2022 to Q3 2024.
- Lyell Immunopharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -30 %, a 36.1% decline year-over-year.
- Lyell Immunopharma, Inc. annual Return On Assets for 2023 was -28.8 %, a 57.5% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)